(Q57610659)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729660%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729660%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

main subject

Cryptococcus neoformans

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729660%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Chang Shan-chwen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729660%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Chien-Ching Hung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729660%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

C C Shih

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729660%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K T Luhbd

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729660%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Y S Pan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729660%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

W C Hsieh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729660%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729660%20AND%20SRC:MED&resulttype=core&format=json

Diagnostic Microbiology and Infectious Disease

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729660%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729660%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729660%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

175-183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729660%20AND%20SRC:MED&resulttype=core&format=json

Epidemiologic differences among serotypes of Cryptococcus neoformans

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

A pharmacologic guide to the clinical use of amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

In vitro antifungal susceptibilities of Candida species isolated from the blood

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Prognostic factors in cryptococcal meningitis. A study in 111 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Treatment of disseminated mycotic infectioons. A new approach to amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

5-fluorocytosine in the treatment of cryptococcal and candida mycoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Cryptococcus neoformans in tropical northern Australia: predominantly variant gattii with good outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Serotypes and mating types of clinical strains of Cryptococcus neoformans isolated in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Meningitis due to Cryptococcus neoformans biovar gattii in a Zairean AIDS patient

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Cryptococcus neoformans var gattii in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

A New Species of Filobasidiella, the Sexual State of Cryptococcus neoformans B and C Serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Cryptococcus bacillisporus sp. nov.: Serotype B-C of Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Epidemiologic differences between the two varieties of Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Synergistic Action of Amphotericin B and 5-Fluorocytosine Against Yeast-Like Organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Synergism of Amphotericin B and 5-Fluorocytosine for Candida Species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Cryptococcus neoformans serotype groups encountered in Oklahoma

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Detection of amphotericin B-resistant Candida isolates in a broth-based system

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Serotypes of Cryptococcus neoformans in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Cryptococcus neoformans var. gattii in a Brazilian AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Cryptococcus neoformans varieties as agents of cryptococcosis in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Clinical epidemiological study of 171 cases of cryptococcosis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Biochemical serogrouping of clinical isolates of Cryptococcus neoformans.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

The variety of Cryptococcus neoformans in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Incidence and factors associated with extrapulmonary cryptococcosis among persons with HIV infection in Los Angeles County

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Clinical and Host Differences Between Infections with the Two Varieties of Cryptococcus neoformans

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Clinical isolates of Cryptococcus neoformans from Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Therapy of Cryptococcosis with a Combination of Flucytosine and Amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

5-Fluorocytosine in the Treatment of Mycotic Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900137-6

7 January 2021

10.1016/S0732-8893(99)00137-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729660%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference